It has recently been shown that an adenovirus mutant lacking expression of the large E1B protein (DE1B) selectively replicates in p53 de®cient cells. However, apart from the large E1B protein the adenovirus early region encodes the E1A and E4orf6 proteins which also have been reported to aect p53 expression as well as its functioning. After infection with wild-type adenovirus we observed a dramatic decrease in wild-type p53 expression while no down-regulation of p53 could be detected after infection with the DE1B virus. The dierent eects of the wild-type and DE1B adenovirus on p53 expression were not only found in cells expressing wild-type p53 but were also observed when tumor cells expressing highly stabilized mutant p53 were infected with these two viruses. Infection with dierent adenovirus mutants indicated the importance of a direct interaction between p53 and the large E1B protein for reduced p53 expression after infection. Moreover, coexpression of the E4orf6 protein was found to be required for this phenomenon, while expression of E1A is dispensable. In addition, we provide evidence that p53 is actively degraded in wild-type adenovirus-infected cells but not in DE1B-infected cells.
Introduction
DNA tumor viruses have in common that they inactivate the tumor suppressor protein p53. This inactivation is essential for lytic infection and also in cell transformation products of these viruses inactivate p53. For instance, the E6 protein of the human papilloma viruses (HPV) 16 and 18 binds to p53 and, via interaction with the cellular E6 associating protein, causes ubiquitin-regulated degradation of p53 (Huibregtse et al., 1993a; Schener et al., 1990) . Also the large E1B protein of human adenovirus Ad2 and Ad5 and the large T antigen of SV40 bind to p53. Although in these cases p53 is stabilized rather than degraded, association of p53 with the viral proteins results in an inactivation of the tumor suppressor protein (Linzer and Levine, 1979; Oren et al., 1981; Reich et al., 1983; Zantema et al., 1985) .
Detailed analysis of the eects of the adenovirus large E1B protein on p53 showed that the nononcogenic adenovirus serotypes (Ad2 and Ad5) express a large E1B protein which directly interacts with p53 (Sarnow et al., 1982) and subsequently cause migration of nuclear p53 into cytoplasmic bodies (Zantema et al., 1985) . Many investigators have not been able to ®nd a direct interaction of p53 with the large E1B protein of the oncogenic adenovirus type 12, although expression of Ad12 large E1B was found to cause p53 stabilization (Grand et al., 1993; Mak et al., 1988; van den Heuvel et al., 1990 van den Heuvel et al., , 1993 Zantema et al., 1985) . Only recently, direct interaction of Ad12 large E1B with p53 has been described (Grand et al., 1994 (Grand et al., , 1996 , but this binding seems to be less stable than the one between Ad2 or Ad5 large E1B and, moreover, does not change the nuclear localisation of p53 (Zantema et al., 1985) .
The interaction between p53 and the large E1B protein of Ad2 has extensively been studied by Berk and coworkers. They have shown that the area between amino acid 224 and 354 of the large E1B protein was essential for the binding to p53 . This binding does not disrupt the DNA binding capacity of p53 but tethers, via p53, the transcription-repressing domain of E1B to p53-responsive genes and results in inhibition of transcription activation by p53 (Yew and Berk, 1992; Yew et al., 1994) . Bischo and coworkers reported recently that an adenovirus mutant lacking the expression of the large E1B protein selectively replicates in p53-de®cient cells (Bischo et al., 1996) . This result suggested that functionally active p53 protects cells against lytic infection by the DE1B adenovirus. However, the large E1B protein is not the only adenoviral protein reported to aect p53. Lowe and Ruley have shown that also the E1A proteins can cause p53 stabilization (Lowe and Ruley, 1993) . Moreover, the E1A proteins have been observed to inhibit transcription activation by p53 (Steegenga et al., 1996) , as well as p53-mediated repression of transcription (Horikoshi et al., 1995) . More recently, a third component of the adenovirus early region has been identi®ed to aect p53: the E4orf6 gene product. Like the E1A and E1B proteins, the E4orf6 protein can inhibit both activation and repression of transcription by p53 (Dobner et al., 1996; Nevels et al., 1997) . In contrast to the eects of E1A and E1B, however, E4orf6 was observed to decrease the p53 half-life in adenovirus-transformed cells and thereby reducing the p53 expression levels (Moore et al., 1996) .
After infection of cells with the DE1B virus, as described by Bischo and coworkers, the p53 regulators E1A and E4orf6 are still expressed. The aim of our study was to examine the eects of these adenoviral proteins on p53 after infection by the DE1B adenovirus. In agreement with what has been published by Grand et al. (1994) , we found a signi®cant reduction in p53 expression after infection of p53 pro®cient cells with wild-type adenovirus while the DE1B virus did not cause down-regulation of p53 in these cells. With the use of dierent E1B adenovirus mutants we found that binding of p53 to the large E1B protein is essential for the observed decrease in p53 expression. We provide evidence that the decreased p53 expression in the infected cells is caused by a dramatic reduction of the half-life of the protein. For the active degradation expression of both the large E1B protein and the E4orf6 protein is essential while the process is independent of E1A expression.
Results
Complex formation between the large E1B protein and p53 after adenovirus infection is correlated with decreased p53 expression levels
To examine the eect of the large E1B protein on the expression levels of p53 after adenovirus infection, the rhabdoid kidney tumor cell line G401, containing functionally wild-type (wt) p53 (Steegenga et al., 1995b) , was infected with the wt and DE1B(=dl1520) adenovirus. Lysates were made 0, 8 and 22 h postinfection and p53 expression levels were analysed by Western Immunoblotting. As can be seen in Figure 1a , 22 h after infection with the wt virus a dramatic decrease was observed in the expression levels of p53. In contrast, no reduction of p53 protein was found when the cells were infected with the DE1B adenovirus while expression of the early adenoviral proteins E1A, E4orf6, E4orf6/7 and E1B/21 kDa was comparable in both cases (Figure 1a) . We used two previously described adenovirus mutants to analyse the eect of complex formation between p53 and the large E1B protein on p53 expression after infection in more detail. The R443 adenovirus mutant produces a large E1B protein which still can bind to p53 but has lost its ability to inhibit transcription activation by p53 due to an insertion of 4 aa on position bp3342 and the H326 mutant expresses a large E1B protein not capable in binding to p53 due to an insertion of 4 aa on position bp2991 . G401 cells were infected with either the R443 or the H326 adenovirus mutant and again p53 expression was examined by Western Immunoblotting. As can be seen in Figure 1a , after infection with the R443 virus, the p53 expression level is decreased, comparable to the situation observed after infection with the wt virus. However, after infection with the H326 mutant, no decreased p53 expression was found. Together these results indicate that, due to a direct interaction between p53 and the large adenovirus protein, p53 protein levels are downregulated after adenovirus infection.
The eects of infection with the same set of adenoviruses on p53 expression levels were also investigated in the osteosarcoma cell line U2OS, to check whether the observed eects could be detected in other wt p53 expressing cells. Like in the G401 cells, a signi®cant decrease in p53 expression was observed in U2OS cells after infection with the wt adenovirus and R443 mutant, while slightly increased p53 expression was observed after infection with the DE1B or H326 virus (Figure 1b ).
Reduced expression of mutant p53 after adenovirus infection
p53 is the most frequently mutated gene in human tumors and mutations in the p53 gene lead, in general, to conformational changes, functional loss and increased protein stability. We were interested whether infection with wt adenovirus leads to down-regulation of highly stabilized mutant p53 in human tumor cell lines. As can be seen in Figure 1b, Adenovirus infection overrules the eect of adenovirus transformation on p53 expression
The results presented in Figure 1 indicate the requirement for expression of the large E1B protein for decreased p53 expression after adenovirus infection. In contrast, E1B causes stabilization of p53 after transformation resulting in increased expression levels of the protein.
To analyse these apparently contradictory eects into more detail, we stably transfected G401 cells with the Ad5 E1B/55 kDa gene. Western Immunoblotting showed that, in agreement with earlier studies (van den Heuvel et al., 1993; Zantema et al., 1985) , expression of the non-oncogenic Ad5 E1B/ 55 kDa resulted in increased p53 expression ( Figure 2a ). Subsequently, these stable transfectants were infected with the wt and mutant adenoviruses and the eects on p53 expression were examined. As can be seen in Figure 2b , a dramatic reduction in p53 levels was observed after infection of two independent stable transfectants, G55C2 and G55C5, with wt adenovirus at 22 h after infection. This result indicates that the stabilized p53 in these transfectants is still sensitive for the down-regulatory eect of adenovirus infection. Moreover, the DE1B and the H326 mutants, which both did not cause decreased expression of p53 in all the cell lines tested so far, showed the same reduction in p53 as the wt and R443 mutant virus in both stable transfectants. These observations indicate that stable expression of the large E1B protein in cells can complement for the defects of the mutant E1B viruses and targets p53 to be down-regulated after adenovirus infection.
For a long time it was thought that the large E1B protein of the oncogenic adenovirus serotype Ad12 did not associate with p53, but Grand and colleagues showed recently that the Ad12 E1B/54 kDa protein can bind directly to p53 (Grand et al., 1994 (Grand et al., , 1996 , although this interaction seemed to be less stable. To examine the eect of the Ad12 large E1B protein on the expression of p53 after infection, we stably transfected the G401 cell line with a Ad12 E1B/ 54 kDa expression vector resulting in increased p53 expression levels as expected ( Figure 2a ). The situation observed after infection with the wt and mutant adenovirus diered from the one observed after infection of the stable transfectants expressing the Ad5 E1B/55 kDa protein. Ad12 E1B/54 kDa expression only partially compensates for the mutated E1B proteins of the DE1B and H326 viruses in the two independent stable transfectants tested. Strongly decreased p53 expression was again found after infection with the wt and R443 virus. To exclude the possibility that the intermediate eects observed after infection with the DE1B and H326 virus were caused by low E1B/54 kDa expression levels, we examined the function of p53 in these stable transfectants. The results presented in Figure 2c show that treatment of the Ad12 E1B/54 kDa transfectants with camptothecin, an inducer of DNA damage and thereby an activator of p53 (Nelson and Kastan, 1994) , did not result in increased p53 expression and activation of the p53-responsive gene p21
Waf1 could not be detected, in contrast to parental G401 cells. From these data we conclude that the expression levels of the Ad12 large E1B protein in 
Figure 2 Endogenously expressed Ad5 large E1B protein can completely overrule the eects of the DE1B and H326 on p53 expression after infection while Ad12 large E1B has only a partial eect. (a) Total cell lysates of G401 cells stably transfected with either the non-oncogenic Ad5 large E1B or the oncogenic Ad12 large E1B were examined by Western Immunoblotting on p53, Ad5 E1B/55 kDa and Ad12 E1B/ 54 kDa expression, respectively. (b) The same stable transfectants were mock infected or infected with the wt, DE1B, R443 or H326 adenovirus. Western Immunoblotting of the lysates of the Ad5 E1B stable transfectant showed the complete disappearance of p53 expression at 22 h after infection with all four viruses. In the lysates made of the Ad12 E1B stable transfectants, p53 was almost absent after infection with the wt or R443 virus but only partially reduced after infection with the DE1B and H326 adenovirus. (c) G401 cells and the Ad12 E1B/54 kDa stable transfectants were incubated with camptothecin (300 nM) for 20 h. The results of Western Immunoblotting show increased expression of p53 and p21 Waf after camptothecin treatment of the parental G401 cells but no induction was found in the E1B/ 54 kDa expressing transfectants with the DNA damaging agent these stable transfectants is sucient to inactivate this p53 function completely, indicating that the partial eects on p53 expression found after infection with the DE1B and H326 adenoviruses are probably caused by a dierence in the interaction of the Ad5 and Ad12 large E1B proteins with p53.
Active degradation of p53 by adenovirus infection
The almost complete disappearance of wt p53 at 22 h after infection by the wt and R443 adenovirus might be caused by adenovirus-induced inhibition of host cell protein synthesis. It has been reported previously that, due to complex formation between the large E1B and the E4orf6 proteins, the transport of newly synthesized host cell mRNA from the nucleus to the cytoplasm is blocked after adenovirus infection (Ornelles and Shenk, 1991) , thereby inhibiting host cell protein synthesis. The reduction of highly stable mutant p53 in the C33A and MD468 cells and the stabilized p53 in the large E1B expressing transfectants however, can not solely be explained by this process. We previously examined the stability of p53 in the MD468 cells and found the half-life of the mutant p53 protein to be approximately 20 h (Steegenga et al., 1995a) . This means that even when the adenoviral proteins shut o host cell protein synthesis, at 22 h after infection at least half of the total amount of p53 should still be present. Based on these data we expect p53 to be actively degraded after adenovirus infection. To test this hypothesis MD468 cells were mock-infected, or infected with wt or DE1B adenovirus and at 8 h after infection, a time point at which we found clear expression of E1B/55 kDa, E4orf6 and E1A (Figure 1a) , a pulse chase experiment was performed. As can be seen in Figure 3a and b, p53 in the mock infected MD468 cells is highly stable. Treatment of the cells with the wt virus, however, results in a very rapid degradation of the mutant p53, an eect not observed after infection with the DE1B adenovirus. These results prove that p53 is indeed actively degraded after infection with wild-type adenovirus.
Apart from the active degradation of p53, inhibition of host cell protein synthesis might contribute to the decreased p53 levels observed at 22 h post-infection. When we metabolically labelled infected G401 cells for 2 h prior to isolation we found no changes in the p53 synthesis at 8 h post infection but a signi®cant decrease in p53 synthesis was observed at 22 h post infection. As can be seen in Figure 3c at 22 h post infection in the wild-type and R443 infected cells the strongest reduction in p53 was found but also the DE1B and the H326 mutant from which the mutated large E1B protein can not complex to the E4orf6 protein anymore (Rubenwolf et al., 1977) showed a strong decrease in the synthesis of p53. These results indicate that the down-regulation of host cell protein synthesis is not solely caused by the large E1B-E4orf6 complex but that additional factors are involved. Since all viruses cause signi®cant down-regulation of the p53 synthesis at 22 h post infection while reduction of the p53 expression analysed by Western Immunoblotting (Figure 1 ) was only observed after infection with the wild-type and R443 adenoviruses we conclude that these two viruses make use of a speci®c mechanism to cause down-regulation of the cellular p53 expression levels.
The role of the E4orf6 protein in the degradation process
The results we have outlined above indicate an important role for E1B in the down-regulation of Figure 3 Rapid degradation of mutant p53 in the MD468 cells infected with wt adenovirus. (a) MD468 cells were mock infected or infected with wt or DE1B adenovirus and 8 h after infection the cells were metabolically labelled for 2 h. Subsequently, the cells were incubated with normal tissue culture medium and at dierent time points after labelling lysates were made. p53 was immunoprecipitated from the lysates by a mixture of PAb 122 and 1801 and loaded on a SDS-polyacrylamide gel. (b) The same gels were analysed by phosphorImaging which shows a reduction of the highly stable p53 to approximately 30 min after infection with wt adenovirus. (c) G401 cells were infected and metabolically labelled for 2 h prior to isolation. p53 was immunoprecipitated from the lysates and loaded on a SDS-polyacrylamide gel which was subsequently analysed by PhosphorImaging. The experiment was performed in duplicate and the error bars represent the variation between the two experiments p53 after adenovirus infection. Since the large E1B protein on its own causes stabilization of p53, there has to be at least one additional viral protein which, in cooperation with the large E1B, is responsible for the degradation of p53 after infection. Since it has recently been reported that the E4orf6 protein can decrease the p53 half-life in 293 cells expressing both E1A and E1B (Moore et al., 1996) , the E4orf6 protein seems to be a likely candidate. To test this hypothesis, G401 cells were infected with the previously described DE4orf6 adenovirus mutant dl355 (Halbert et al., 1985) and as can be seen in Figure 4a , no decrease in the p53 expression was observed at 1 or 2 days post infection but, in contrast, a slight increase was detectable. This increased p53 expression is probably due to stabilization of p53 by the E1A and large E1B proteins. Apparently, in the absence of the E4orf6 protein the large E1B can not sensitise p53 for active degradation. As can be seen in Figure 4a after infection with the DE4orf6 mutant expression of the E4orf6/7 gene product could still be detected indicating that this protein can not down-regulate p53 expression together with the large E1B protein.
As a control we infected two independent G401 transfectants stably expressing the E4orf6 protein with the DE4orf6 virus. Figure 4a shows that already at day one after infection, p53 expression is strongly reduced in the GE4-C3 and GE4-C7 cells indicating again that the E4orf6 protein is responsible for the degradation of p53 together with the large E1B protein.
As can be seen in Figure 4b the stably E4orf6 expressing transfectants did not show a change in the p53 expression levels indicating that E4orf6 on its own can not alter the p53 half-life.
The E1A proteins are not required for the active degradation of p53 after adenovirus infection Apart from the large E1B and E4orf6 proteins, also the E1A proteins have been found to in¯uence the p53 half-life (Lowe and Ruley, 1993) . Furthermore, the previously reported reducing eect of the E4orf6 protein on the p53 half-life has been studied in the presence of E1A expression (Moore et al., 1996) and in all our infection experiments presented so far, the E1A proteins were coexpressed. To examine whether the E1A proteins are required for the degradation of p53 by the Ad5 large E1B and E4orf6 proteins, a G401 transfectant stably expressing the large E1B was infected with Ad5 CMVLacZ. In this recombinant virus the E1 region has been replaced by the E. coli LacZ gene and thus can not express the E1A and E1B proteins but is able to express the E4orf6 protein (Kolls et al., 1994) . If E1A expression is not required for the active degradation of p53, infection of the G55C5 transfectant should result in decreased p53 expression. Indeed, when this stable transfectant is infected with the CMVLacZ adenovirus, at day 2 post-infection decreased p53 was observed and at three days after infection p53 has almost completely disappeared (Figure 5a ). Although we detect downregulation of p53 in the absence of the E1A proteins the kinetics of the disappearance is delayed compared to the situation observed after wt adenovirus infection ( Figure 1a) . As can be seen in Figure 5a also the expression of E4orf6 is retarded which can be explained by the previously reported stimulation of E4orf6 expression by the E1A proteins (Marcellus et al., 1996) . Infection of the parental G401 cells did not show decreased p53 expression after infection with the CMVLacZ adenovirus while the other independent large E1B transfectant G55C2, showed the same disappearance of p53 as was found for the G55C5 (Figure 5b ), E4orf6 protein expression was in all situations comparable (Figure 5a and data not shown). As expected, we could not detect E1B nor E1A expression after infection with the CMVLacZ virus (data not shown). The G401 control transfectant expressing the E1A proteins did not show decreased p53 levels after infection with the CMVLacZ adenovirus (Figure 5c ). From these data we conclude that E1A expression is not required for the active degradation of p53 after adenovirus infection.
E1B and E4orf6 decrease p53 expression after transient transfection
To prove that the large E1B and E4orf6 proteins together can target p53 for active degradation not only after adenovirus infection but also in a more direct assay we performed transient transfections in p53-negative Hep3B cells. As can be seen in Figure 6 increased p53 expression was found after cotransfec- However, when the large E1B and the E4orf6 were together cotransfected with p53 a signi®cant reduction in the p53 expression was observed con®rming our previous conclusion that together these adenovirus proteins target p53 for active degradation.
Discussion
Wt p53 has been reported to protect cells against lytic infection by an adenovirus mutant lacking expression of the large E1B protein (DE1B) but not against infection by wt adenovirus (Bischo et al., 1996) . This result suggested that the protective function of wt p53 against virus replication can be inhibited by the large E1B protein. Indeed, we observed strongly decreased expression of wt p53 after infection with the wt adenovirus while no reduction in p53 was detectable after infection by the DE1B virus. These dierent eects on p53 expression by the two viruses were not only detected for wt, instable p53 but also for highly stabilized mutant p53. By performing pulse chase experiments we measured a dramatic reduction of the half-life of mutant p53 in the MD468 cells after infection with the wt adenovirus while the DE1B virus did not alter the half-life of p53. From these results we conclude that active degradation of p53 takes place after wt adenovirus infection. After infection with the DE1B virus we found a slight increase in wt p53 expression in the G401 and U2OS cells and no enhancement at all of the mutant p53 levels in the MD468 and C33A cells. Grand and colleagues also found enhanced p53 expression after infection with an adenovirus mutant lacking expression of the large E1B protein, but the eect was much stronger. They showed that this eect was caused by the E1A proteins (Grand et al., 1994 (Grand et al., , 1995 . The fact that we do not observe an increase in the half-life of mutant p53 in MD468 and C33A cells after DE1B infection is probably due the already high stability of p53 in these cells. Also in G401 cells p53 is already partially stabilized (Steegenga et al., 1995a) explaining the relative minor eect of the E1A proteins on p53 in these cells compared to the results published by Grand et al. (1994 Grand et al. ( , 1995 .
The data presented by Bischo and colleagues indicate that the p53 binding domain of the adenovirus large E1B protein is essential for lytic infection in wt p53 expressing cells (Bischo et al., 1996) . We found that the previously described H326 mutant virus , expressing a large E1B protein not capable to bind to p53, could not sensitise p53 for active degradation indicating that a direct interaction between the two proteins is essential. It has recently been shown that the mutation in the large E1B protein of the H326 virus also causes loss of the binding of this protein to the E4orf6 product and we can not exclude that this property is also involved in the degradation of p53 after viral infection. The results we have obtained after infection of the Ad5 and the Ad12 large E1B stable transfectants show that the stability of the binding of p53 to the dierent E1B proteins is correlated with the degree in which these large E1B proteins can compensate for the mutations in the DE1B and H326 adenovirus. These data con®rm our hypothesis that a direct interaction between the large E1B and p53 proteins is important for decreased p53 levels after infection. In cell transformation, adenovirus large E1B protein, like the E1A proteins, cause p53 stabilization (Lowe and Ruley, 1993; Zantema et al., 1985) . This suggested to us that after adenovirus infection at least one additional adenoviral protein has to be expressed The large E1B and E4orf6 proteins together can downregulate p53 in transient transfections. p53-negative Hep3B cells were transiently transfected with 0.1 mg pCMVp53 and cotransfected with either pCMVneo, pCMV-E1B, pCMV-E4orf6 or combinations of these plasmids as indicated. Lysates were made at 24 h after transfection and analysed by Western Immunoblotting to observe p53 degradation. Active degradation of p53 was not observed after infection of G401 cells with an DE4orf6 adenovirus mutant unless the G401 cells stably expressed the E4orf6 protein. Infection of G401 cells with a CMVLacZ virus, lacking the E1A and E1B genes but expressing the E4orf6 protein, did not signi®cantly alter the p53 expression. However, when the CMVLacZ virus was used to infect G401 cells stably expressing the large E1B protein, we observed down-regulation of p53, indicating that the E4orf6 protein together with the large E1B protein can induce degradation of p53. Since the E1A proteins were not expressed under these conditions we conclude that the latter proteins are dispensable for the active degradation of p53 after adenovirus infection.
In most normal cells the p53 protein is expressed at very low levels due to the relatively short half-life of the protein. Maki and Howley showed that alteration in p53 ubiquitination might be responsible for the enhanced p53 protein stability induced by u.v. radiation (Maki and Howley, 1997) . However, Kubbutat and Vousden reported that also inhibition of calpain, a nonlysosomal calcium-activated neutral protease, is correlated with increased p53 protein stability (Kubbutat and Vousden, 1997) . Moreover, the observation made by Maki and Howley that p53 stabilization after X-ray radiation is not correlated with changes in the ubiquitination of the tumor suppressor protein also indicates that apart from ubiquitination at least one other mechanism can regulate p53 stability in vivo (Maki and Howley, 1997) . The rapid degradation of p53 as a result of HPV 16 or 18 infections has extensively been studied and it has been shown that the HPV E6 protein can, via interaction with cellular protein E6-AP, enhance ubiquitin-mediated degradation of p53 (Huibregtse et al., 1993a,b; Schener et al., 1990) . Not only wt but also mutant p53 can be targeted for degradation by the HPV E6 (Crook and Vousden, 1992; Schener et al., 1992) . Comparable to the situation after HPV infection, we report here the rapid degradation of both wt and mt p53 after adenovirus infection. The question remains whether the adenovirus proteins also activate ubiquitin-mediated degradation of p53 and, if so, whether the E6-AP is involved in this degradation pathway. On the other hand, since also calpain can mediate p53 protein degradation it remains possible that adenoviruses activate an alternative degradation pathway. The exact role of the E4orf6 protein together with the large E1B in the enhanced degradation of p53 is also not clear yet. Alterations in the cellular environment rather than resistance to normal degradation were reported to be responsible for the enhanced stability of mutant p53 (Vojtesek and Lane, 1993) . It has been shown that after transfection of 293 cells with E4orf6 p53 moved from the cytoplasmic bodies to the nucleus (Moore et al., 1996) . This translocation of p53 might be important for the enhanced protein degradation. Another option is that, bound to both E1B and E4orf6 the p53 conformation is changed in such a way that the protein is sensitised for proteolytic cleavage. Since the MDM2 protein binds to the same region of p53 as the large E1B it would be interesting to examine whether overexpression of this cellular protein can take over the eect of the viral protein. The molecular mechanism responsible for the decreased p53 half-life after infection with wt adenovirus and the role of the large E1B and E4orf6 proteins in this process are under current investigation.
Our results show that after infection with the DE1B virus both wt and mutant p53 remain present. In general, mutant p53 proteins have lost the normal functions of the tumor suppressor protein (reviewed in: Zambetti and Levine, 1993) and, in addition, have gained new properties (Dittmer et al., 1993) . Although mutant p53 expression is not altered after infection with the DE1B adenovirus, since mutant p53 has lost its wt activity it can not protect cells against lytic infection by the adenovirus mutant. The eects of the DE1B virus on wt p53 on the other hand is less clear. Although the E1A and E4orf6 proteins did not induce signi®cant changes in p53 expression in the infected cells these proteins have also been shown to aect transcription regulation by p53 (Dobner et al., 1996; Horikoshi et al., 1995; Nevels et al., 1997; Steegenga et al., 1996) . There is no evidence however, that p53 protects cells against lytic infection by the DE1B virus via regulating the expression of p53-target genes. P53 has been reported to be involved in of a number of dierent cellular processes such as replication, differentiation of speci®c cell types, G1 and G2/M cell cycle regulation, apoptosis, id. (reviewed in: Gottlieb and Oren, 1996; Ko and Prives, 1996) . These functions of p53 might be dierently aected by the independent viral proteins. It is possible that one or more of these additional features of p53 have to be inhibited by the large E1B protein before lytic infection can take place. Further analysis is necessary to unravel the interference by all the adenovirus proteins in the dierent processes regulated by p53 during infection.
Materials and methods

Tissue culture and cell lines
The rhabdoid kidney tumor cell line G401 subclone G401.6TG.C6 (Weissman et al., 1987) and the cell lines MD468 (Nigro et al., 1989) , C33A (Schener et al., 1991) , U2OS (Diller et al., 1990) , 911 (Fallaux et al., 1996 ), Hep3B (Puisieux et al., 1993 and W162 (Weinberg and Ketner, 1983) were grown in Dulbecco's modi®ed Eagle's medium (DMEM) plus 10% FBS. The large E1B expressing stable transfectants were obtained by transfecting G401 cells with respectively the pCMV-55K (van den Heuvel et al., 1993) or the pCMV-54K (van den Heuvel et al., 1993) . The G401-E4 stable cell lines were made by transfection of the pCMV34K plasmid (Dobner et al., 1996) into these cells. The G401 cell lines expressing Ad5 E1A and E1B/21kDa were obtained by cotransfection of pRSV-5E1A (Jochemsen et al., 1987 )+pCMV21K (Steegenga et al., 1995a . All stable transfectants were cultured in the same medium as the parental G401 cell line with the addition of G418 (300 mg/ml).
Adenoviruses and virus techniques
Besides the wt adenovirus type 5 the following mutant viruses were used: the DE1B (=dl1520 or ONYX-0.015) (Bischo et al., 1996) , R443 and H326 adenoviruses contain mutations in the large E1B gene as described earlier . In the CMVLacZ adenovirus the E1 region has been replaced by the E. coli lacZ gene under the control of the heterologous CMV promoter (Kolls et al., 1994) . In the DE4orf6 virus (dl355) the region between bp 2331 and 2346 of the orf6 gene has been deleted (Halbert et al., 1985) .
Small scale productions of adenovirus lots were performed essentially according to Stratford-Perricaudet and Perricaudet (Stratford-Perricaudet, 1991) . Brie¯y, near-con¯uent 911 monolayers in 600 ml¯asks were infected with approximately 5 PFUs per cell in 2 ml PBS containing 2% FBS. After 1 h at 378C, the inoculum was replaced by fresh normal tissue culture medium. After 48 h the nearly completely detached cells were harvested and collected in 1 ml PBS+1% FBS. Virus was isolated from the producer cells by three cycles of¯ash-freeze/thawing. The lysates were cleared by centrifugation at 3000 r.p.m. for 10 min. The crude virus supernatants were layered onto CsCl cushions, 2 ml of heavy (1.45 gram/cm 3 CsCl, 10 mM Tris pH 8.1, 1 mM EDTA) and 4 ml of light (1.20 gram/cm 3 CsCl, 10 mM Tris pH 8.1, 1 mM EDTA) CsCl and centrifuged in an SW41 rotor at 32 000 r.p.m. for 1 h at 178C. The collected virus bands were mixed with 1.33 gram/cm 3 CsCl, 10 mM Tris pH 8.1, 1 mM EDTA and centrifuged in a 70Ti rotor at 55 000 overnight at 178C. To remove the CsCl, the collected virus bands were mixed with one volume of dialysis buer (25 mM Tris, 137 mM NaCl, 5 mM KCl, 0.73 mM Na 2 HPO 4 , 0.9 mM CaCl 2 , 0.5 mM MgCl 2 , pH 7.45) and dialysed against 2 litres of the dialysis buer which was refreshed four times, at 48C. The ®nal dialysis was performed in the same buer containing 17% glycerol. Virus stocks were stored at 7808C until further use.
Plaque assays were performed as described by Graham and Prevec (1991) . Brie¯y, adenovirus stocks were serially diluted in 2 ml of DMEM without serum and added to near con¯uent 911 cells in six-well plates. After 2 h of incubation at 378C the medium was replaced by DMEM containing 0.85% agarose (Sigma), 12.3 mM CaCl 2 , 0.0025% Lglutamine and 2% FBS.
Small scale productions and plaque assays for the dl355 adenovirus were performed according to the above described protocols but in W162 cells instead of in 911 cells. To examine the eect of adenovirus infection on p53 expression levels exponentially growing cells were infected on 50 mm petridishes with a MOI of 100 PFUs per cell unless mentioned otherwise. The infections were performed by incubating the cells for 30 min at 378C with the virus diluted in 500 ml PBS+2% FBS. Afterwards, the virus was removed and normal tissue culture medium was added to the cells. At the indicated time points the cells were washed twice with ice-cold PBS and lysates were made in Giordano/E1A buer (50 mM Tris-HCL pH 7.4, 0.25 M NaCl, 0.1% Triton, 5 mM EDTA, 1 mM PMSF, 1 mM orthovandadate, 1 mM leupeptin, 0.5 mM trypsin inhibitor and 0.1 mM aprotinin). Lysates were cleared by centrifugation at 14 000 r.p.m. for 10 min. The protein concentrations of the lysates were measured by the Bradford Assay (Biorad). All infections were performed at least two times.
Western Immunoblotting
For the experiments as depicted in Figures 1, 2 , 4, 5 and 6, 10 mg of the total cell lysates were boiled for 5 min in Laemmli sample buer and subsequently separated on 12.5% SDS-polyacrylamide gels. Subsequently, the proteins were blotted onto Protran nitrocellulose membrane (Scheicher and Schuell). The membranes were incubated overnight with the ®rst antibodies: DO-1 (SanverTECH, p53-speci®c monoclonal antibody), M73 (E1A-speci®c monoclonal antibody), 1G11 (E1B21 kDa-speci®c monoclonal antibody). RSA3 (E4orf6-speci®c monoclonal antibody), A1C6 or 2A6 (both E1B/55 kDa-speci®c monoclonal antibodies), 8A9 (E1B/54 kDa-speci®c monoclonal antibody) or SC397 (SanverTECH, p21
Waf1 -speci®c polyclonal antibody). Immune complexes were detected by enhanced chemiluminescence (Amersham).
Pulse chase experiment and metabolic labeling
Exponentially growing G401 cells were infected under the same conditions as described in the section:`Adenoviruses and virus techniques'. At 8 h after infection the cells were labelled with 80 mCi express protein labeling mix (NEN Life Science) for 2 h. After labeling, the cells were washed once with PBS and subsequently maintained for dierent time intervals in the normal tissue culture medium. Subsequently, the cells were washed twice with ice-cold PBS and lysates were prepared in Giordano/E1A buer (50 mM Tris-HCL pH 7.4, 0.25 M NaCl, 0.1% Triton, 5 mM EDTA, 1 mM PMSF, 1 mM orthovandadate, 1 mM leupeptin, 0.5 mM trypsin inhibitor, 0.1 mM aprotinin). Lysates were cleared by centrifugation at 14 000 r.p.m. for 10 min and subsequently, immunoprecipitations were performed with a mixture of PAb 122 (p53-speci®c monoclonal antibody) and PAb 1801 (SanverTECH, p53-speci®c monoclonal antibody). Immunoprecipitates were washed three times with Giordano/E1A buer, resuspended in Laemmli sample buer, boiled for 5 min and separated on 10% SDSpolyacrylamide gels. The gels were ®xated for 1 h in methanol (25%)/acetic acid (7%) and incubated for 30 min in 1 M Sodiumsaliculate. The dried gels were subsequently exposed to Kadac XAR-5 ®lms at 7808C and to a PhosphorImager screen which was analysed by B&L systems Molecular Dynamics software. The experiment was performed twice under these conditions showing reproducibly the results as presented in Figure 4a . For the metabolic labeling cells were infected as described in the section:`Adenoviruses and virus techniques'. At 6 and 20 h post-infection the infected cells were labeled for 2 h with 80 mCi express protein labeling mix (NEN Life Science). Afterwards lysates were made in Giordano/E1A buer and the rest of the procedure was executed following the protocol of the pulse chase experiment.
Transient transfections
Hep3B cells were transiently transfected by way of the calcium-phosphate precipitation method on 60-mm petri dishes (Steegenga et al., 1995a) . 0.1 mg pCMV-p53 was cotransfected with pCMV-55K and/or pCMV34K as indicated in Figure 6 . With the addition of pCMV-neoBam the total amount of CMV-containing plasmid was adjusted to 5.1 mg in all precipitates and in addition 4.9 mg of salm sperm DNA was used as carrier DNA. Lysates were made in Giordano/E1A buer and protein concentrations were measured by the Bradford (Biorad) assay. From each sample 10 mg protein was loaded on a SDS page, blotted onto nitrocellulose and analysed with the 1801 (SanverTECH), A1C6 and RSA3 antibodies.
